SEC Comment Letter 0000000000-25-003356 to SaverOne 2014 Ltd. (SVRE)
SaverOne 2014 Ltd.
Date: March 28, 2025 · CIK: 0001894693 · Accession: 0000000000-25-003356
AI Filing Summary & Sentiment
Reasoning
Letter
Re: SaverOne 2014 Ltd. Draft Registration Statement on Form F-1 File No. 377-07808 Submitted March 21, 2025 Dear Ori Gilboa:
March 28, 2025
Ori Gilboa Chief Executive Officer SaverOne 2014 Ltd. Em Hamoshavot Rd. 94 Petah Tikvah, Israel
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Edwin Kim at 202-551-3297 with any questions.
Sincerely,
Division of
Corporation Finance
Office of
Technology
cc: David Aboudi, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 28, 2025 Ori Gilboa Chief Executive Officer SaverOne 2014 Ltd. Em Hamoshavot Rd. 94 Petah Tikvah, Israel Re: SaverOne 2014 Ltd. Draft Registration Statement on Form F-1 File No. 377-07808 Submitted March 21, 2025 Dear Ori Gilboa: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Edwin Kim at 202-551-3297 with any questions. Sincerely, Division of Corporation Finance Office of Technology cc: David Aboudi, Esq. </TEXT> </DOCUMENT>